Connect with us

HEALTH

Israeli Scientists Say They’ll Have Cure for Cancer Within a Year. Here’s Why That’s Highly Unlikely

HPSN

Published

on

Scientists at an Israeli biotech company say that they believe they will have a cure for cancer within a year, but experts contacted by say that’s highly unlikely.

The scientists, from Accelerated Evolution Biotechnologies Ltd. (AEBi), told The Jerusalem Post on Jan. 28 that they “believe [they] will offer, in a year’s time, a complete cure for cancer.” But AEBi has not published its findings; instead, the public learned of the claims in the Jerusalem Post article.

According to the Post, the potential treatment is called “MuTaTo,” or “multitarget toxin.” MuTaTo consists of peptides (short strands of amino acids) developed by the scientists that latch onto multiple sites on a cancer cell at once, according to the Post. By binding to multiple sites on a cancer cell, the treatment doesn’t give the cell enough time to mutate again before another peptide in the same mix, this one toxic to cancer cells, swoops in and eradicates the cancer, the scientists claimed. [7 Odd Things That Raise Your Risk for Cancer (and 1 That Doesn’t)]

The researchers said they have tested their approach in mice in a single exploratory study (but their results are supposedly “consistent and repeatable”), and they hope to begin human clinical trials soon, according to the Post.

The claims left other scientists scratching their heads.

Dr. Deanna Attai, an assistant clinical professor in the department of surgery at the University of California, Los Angeles, said that she thinks the Israeli scientists are “making a lot of leaps from what sounds like very preliminary studies.” As such, their claims are just “irresponsible,” Attai told .

“There is no data to review,” said Dr. Robert Maki, the chief scientific officer for the Northwell Health Cancer Institute in New York. “There’s absolutely nothing to be able to look at or examine or read to know what the story is about actually.”

Adding to outside experts’ concern is that the study was conducted only in mice.

“As experience has taught us so many times, the gap from a successful mouse experiment to [an] effective, beneficial application of exciting laboratory concepts to helping cancer patients at the bedside is in fact a long and treacherous journey, filled with unforeseen and unanticipated obstacles,” wrote Dr. Len Lichtenfeld, the chief medical officer of the American Cancer Society, in a blog post responding to the Jerusalem Post story.

“Unfortunately, we must be aware that this is far from proven as an effective treatment for people with cancer, let alone a cure,” Lichtenfeld wrote.

AEBi scientists told the Post that the treatment in fact inhibited the growth of human cancer cells in mice, with no effect on healthy mouse cells.But this doesn’t mean that the treatment would have no effect on healthy human cells, Attai said.

reached out to AEBi for comment. The company replied via email, saying that “We believe that we will offer in a year’s time [when the first person will be treated] a complete cure for cancer.” In addition, AEBi said that this cure will be effective from the first day and that the treatment will last a few weeks with no or few side effects, on the order of a “rush” or “less than a headache.” The company also said the treatment would cost less than the cancer treatments available today. [7 Side Effects of Cancer Treatment, and How to Cope with Them]

But the claim that one treatment can cure all cancers doesn’t seem too likely, Attai said. Cancer cells express different kinds of proteins on their surfaces, so they look different to drugs and the immune system. AEBi’s treatment seems to be attacking multiple proteins on cancer cells, which perhaps may be a “promising” approach initially, she said. But past studies have shown that even if we set up a “roadblock … cancer cells kind of find a way around it,” she added.

Maki agreed: “It would be pretty unusual” for there to be one cure for all cancers. Cancer is different “from one person to the next or even within one person.” Even some parts of a single tumor can be different than other parts, he added.

It’s really “too bad,” Maki told . “Unsubstantiated claims” like this “raise false hope.”

None of this is to say that researchers around the world wouldn’t be happy if AEBi’s treatment worked.

“We all want a cure — physicians, patients, everybody wants the cure,” Attai said. “Unfortunately, it’s just not all that simple.”

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Medical News

MEDICAL10 hours ago

Quick Take: Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics

Systemic antibiotics are commonly used in the treatment of acne. However, the impact of their use on the complete bacterial...

MEDICAL10 hours ago

New herpes zoster vaccine predicted to be more cost effective than predecessor  

1. In a computational model, the new “recombinant zoster vaccine” (RZV) was predicted to be most cost-effective than the previous...

MEDICAL22 hours ago

Chinese population study shows high prevalence of elevated cardiovascular disease risk and low utilization of pharmacotherapy

1. In this national screening project, around 10% of middle-aged Chinese subjects were found to be at “high risk” for...

MEDICAL1 day ago

The KATHERINE trial: trastuzumab emtansine more effective than trastuzumab alone for treating residual HER2-positive breast cancer

1. Patients with residual human epidermal growth factor receptor 2 (HER2)-positive breast cancer after chemotherapy and HER2 targeted therapy had...

MEDICAL2 days ago

Peripheral perfusion-targeted resuscitation does not lower mortality in septic shock patients

1. In this randomized controlled trial, there was no difference in 28-day mortality in patients with early septic shock between...

MEDICAL2 days ago

The CLEAR trial: decolonization routine associated with lower infection risk among MRSA carrier patients

1. Hospitalized patients with known MRSA colonization randomized to undergo a decolonization routine were found to have lower risks of...

MEDICAL3 days ago

Addition of IV acetaminophen with propofol or dexmedetomidine reduces risk of post-operative delirium in older patients undergoing cardiac surgery

1. In this randomized controlled trial, post-operative scheduled intravenous (IV) acetaminophen combined with propofol or dexmedetomidine reduced risk of post-operative...

MEDICAL3 days ago

Nurse-led psychological intervention does not reduce PTSD symptoms in ICU patients

1. In this randomized clinical trial, nurse-led psychological interventions did not reduce PTSD risk at 6 months compared to care...

MEDICAL4 days ago

2-Question Screen Identifies Adolescents at Risk for Future Alcohol Use Disorders

1. The National Institute of Alcohol Abuse and Alcoholism (NIAAA) 2-question screen showed high predictive validity in identifying adolescents at...

MEDICAL4 days ago

MYBPC3 haploinsufficiency results in hypertrophic cardiomyopathy by altering myosin head configurations [PreClinical]

1. Truncating mutations in cardiac myosin-binding protein C (MYBPC3) are a common genetic cause of hypertrophic cardiomyopathy. 2. Haploinsufficiency of...

Advertisement

#CDC

Do you have questions about preventing and managing high #cholesterol? Join @CDCHeart_Stroke and a panel of cholesterol experts for a Facebook Live event on February 25 at 12:30 pm ET. Tune in at facebook.com/millionhearts. #HeartMonth

test Twitter Media - Do you have questions about preventing and managing high #cholesterol? Join @CDCHeart_Stroke and a panel of cholesterol experts for a Facebook Live event on February 25 at 12:30 pm ET. Tune in at https://t.co/rLdeAt7cyx. #HeartMonth https://t.co/6FGXEgv6Wu

HCPs: People with #disabilities are 3 times more likely to have #heartdisease than those without disabilities. In honor of #AmericanHeartMonth, help your patients explore the physical activities suitable for their disability type. bit.ly/2EnsTBx

test Twitter Media - HCPs: People with #disabilities are 3 times more likely to have #heartdisease than those without disabilities. In honor of #AmericanHeartMonth, help your patients explore the physical activities suitable for their disability type. https://t.co/9O33ubwifA https://t.co/SpXpDqLgcP

@Raelove03 CWD and Bovine Spongiform Encephalopathy (BSE, or “Mad Cow Disease”) are both animal prion diseases, a family of rare progressive neurodegenerative disorders. CWD affects deer, elk, reindeer, sika deer and moose, while BSE affects cows.

@Mad_Scientist25 Yes - Chronic Wasting Disease (CWD) is a prion disease that affects deer, elk, reindeer, sika deer and moose. To date, there have been no reported cases of CWD infection in people.

Hunters - be as safe as possible and lower your potential risk of exposure to #ChronicWastingDisease. Take CDC’s recommended steps when hunting in areas with #CWD: bit.ly/2EnQPox.

test Twitter Media - Hunters - be as safe as possible and lower your potential risk of exposure to #ChronicWastingDisease. Take CDC’s recommended steps when hunting in areas with #CWD: https://t.co/aPy5xs4T13. https://t.co/fjxEezzJJt

#lymedisease

@CDC_AMD Hey, can we get more $$$ for research and treatment for #Lymedisease ? Monitoring has done absolutely nothing in regards to testing, treatment, research. It's INSANE that nothing has been done for 40 years about tick borne illnesses.

A negative test does not rule out #LymeDisease Learn more about how to diagnose Lyme here: buff.ly/2sNSHjc

test Twitter Media - A negative test does not rule out #LymeDisease Learn more about how to diagnose Lyme here: https://t.co/OssrqDlLkD https://t.co/4uONqAtSgT

Lyme disease patients (67%) have postponed or avoided medical treatment due to discrimination, disrespect or difficulty obtaining care. #MyLymeData #LymeDisease tinyurl.com/y4rkruvm

test Twitter Media - Lyme disease patients (67%) have postponed or avoided medical treatment due to discrimination, disrespect or difficulty obtaining care. #MyLymeData #LymeDisease https://t.co/Ytok5v5oZl https://t.co/Sfs03xw5Ps

“It gave me a purpose,” she adds of her journey, “and made me find myself all over again.” @AvrilLavigne #LymeDisease #HeadAboveWater people.com/music/avril-la…

#Antiparasitic

Trending

Copyright © 2019. All Rights Reserved. The Human Parasite Support Network.